newsfilter
← Latest News
GlobeNewswire·

Nabriva Therapeutics to Adjourn Extraordinary General Meeting of Shareholders on December 22, 2021

DUBLIN, Ireland and FORT WASHINGTON, Pa., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infec